MedTrace Logo

Is T-lymphocyte Calcineurin Phosphatase Up-regulated by Treatment With Tacrolimus?

NCT00999362 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2009-10-21

No results posted yet for this study

Summary

The purpose of this study is to determine whether calcineurin phosphatase in the T-lymphocytes is up-regulated after long-term treatment with tacrolimus, a calcineurin inhibitor.

Conditions

  • Kidney Transplantation

Sponsors & Collaborators

  • Danish Society of Nephrology

    collaborator OTHER

  • The Danish Kidney Association

    collaborator OTHER

  • Astellas Pharma Inc

    collaborator INDUSTRY

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Dorthe M Mortensen, MD · Department of nephrology, Aarhus University Hospital,Skejby, Denmark

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2009-03-31
Completion
2009-10-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00999362 on ClinicalTrials.gov